Form 4: Galectin Therapeutics Director Reports Stock Transaction
Insider Transaction (Form 4)
Richard E Uihlein, a Director and 10% owner of Galectin Therapeutics Inc, reported multiple transactions in common stock on July 31, 2026.
Summary
- Option exercise/conversion: acquired 31,825,235 Common Stock at $3.00 ($95,475,705) on July 31, 2026; holds 42,162,911 after (Indirect).
- Option exercise/conversion: acquired 2,550,932 Common Stock at $4.05 ($10,331,275) on July 31, 2026; holds 44,713,843 after (Indirect).
- Option exercise/conversion: disposed of 0 Line of Credit Convertible Notes at $95,475,705.00 ($0) on July 31, 2026 (Indirect).
- Option exercise/conversion: disposed of 0 Line of Credit Convertible Notes at $10,331,275.00 ($0) on July 31, 2026 (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Richard E Uihlein — Director, 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-31 | Option exercise/conversion | Common Stock | 31,825,235 | $3 | $95.5M | 42,162,911 |
| 2026-07-31 | Option exercise/conversion | Common Stock | 2,550,932 | $4 | $10.3M | 44,713,843 |
| 2026-07-31 | Option exercise/conversion | Line of Credit Convertible Notes | 0 | $95.5M | — | 0 |
| 2026-07-31 | Option exercise/conversion | Line of Credit Convertible Notes | 0 | $10.3M | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-31 | Option exercise/conversion (31,825,235 shares) |
| 2026-07-31 | Option exercise/conversion (2,550,932 shares) |
| 2026-07-31 | Option exercise/conversion (0 shares) |
| 2026-07-31 | Option exercise/conversion (0 shares) |
Keywords
insider transaction, Form 4, GALT, GALECTIN THERAPEUTICS INC, neutral, Richard E Uihlein
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.